I think 4 in it now at least all on similar timelines, LGP probably a step behind. First openers will have an advantage, but there'll be a lot more to it. Unfortunately marketing probably matters a lot.
VIT, EMD and LGP.
If IHL can get traction in the states and can get some investment, they could probably buyout EMD and LGP, but VIT is a bit of a dysfunctional machine so could be the bigger competitor. VIT has avenues into the medical industry already, and EMD have been in this space for a while.
IHL Price at posting:
4.6¢ Sentiment: None Disclosure: Held